UFC CEO Dana White has undergone one of the most visible physical transformations in sports executive history. Once battling stage-2 hypertension (160/110 mmHg), sleep apnea, and metabolic syndrome, White credits human biologist Gary Brecka and a multi-compound peptide protocol for reversing his biological decline and restoring his energy.
On The Joe Rogan Experience, Brecka recounted the biometric assessment that jolted White into action: a life expectancy calculation projecting he had just 10.4 years left if his vascular inflammation remained unaddressed. White's blood panels revealed dangerously elevated homocysteine and systemic arterial constriction. Within months of adopting Brecka's 10X Health System protocol, White shed over 30 pounds, normalized his blood pressure, and eliminated multiple prescription medications.
The Dana White Peptide Stack
White's regimen combined targeted amino acid sequences engineered to address systemic inflammation, pituitary output, and musculoskeletal recovery:
KPV (Anti-Inflammatory & Gut Barrier Integrity): A tripeptide fragment derived from alpha-MSH, KPV was utilized to downregulate chronic vascular inflammation. Peer-reviewed research in Neuroimmunomodulation demonstrates that KPV inhibits inflammatory cytokines and suppresses nuclear factor kappa B (NF-κB) activation without triggering pigmentary melanocortin side effects. CJC-1295 + Ipamorelin (Growth Hormone Secretagogues): Rather than administering exogenous recombinant HGH, White utilized this dual secretagogue blend to prompt natural, pulsatile growth hormone secretion from the anterior pituitary. Clinical data published in the Journal of Clinical Endocrinology & Metabolism confirms this combination elevates circulating IGF-1 while preserving normal physiological feedback loops. * BPC-157 & TB-500 (The "Wolverine" Healing Stack): To recover from heavy strength training and lingering joint trauma at the UFC Performance Institute, White incorporated pentadecapeptide BPC-157 alongside Thymosin Beta-4. Preclinical studies indexed in PubMed Central show these compounds accelerate angiogenesis (new capillary formation) and upregulate early growth response-1 (Egr-1). Read our comprehensive investigation on the Wolverine Stack peptide protocol for full dosing and safety mechanics.
Editorial Reality Check: While mechanistic and animal data supporting BPC-157, TB-500, and KPV are extensive, large-scale Phase 3 human randomized controlled trials (RCTs) remain limited. Under current FDA regulations, these research compounds are not approved as finished pharmaceutical drugs for general medical treatment.
Beyond Injections: The Metabolic Foundation
Peptides represented only one pillar of White's transformation. Brecka emphasized that signaling peptides cannot compensate for raw micronutrient deficits.
White's protocol resolved a severe MTHFR genetic methylation deficiency through high-dose trimethylglycine (TMG) and methylated B-12, allowing his liver to properly metabolize toxic homocysteine into methionine. His daily routine also incorporates strict ketogenic nutrition, cold plunge sessions at 48°F, pulsed electromagnetic field (PEMF) therapy, and high-intensity red light therapy.
White's case exemplifies how high-performance executive longevity protocols are migrating from niche biohacking forums into the global mainstream. For consumers watching the trend, consulting a qualified endocrinologist and verifying third-party laboratory purity remain critical first steps before considering unapproved compounds.
